Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Electroconvulsive Therapy
100%
Delirium
23%
Antidepressants
20%
Depressed Patients
19%
Modified Electroconvulsive Therapy
19%
Interictal
15%
Immunoglobulin
14%
Seizure Duration
14%
Seizure
14%
Surface Membrane
13%
Repetitive Transcranial Magnetic Stimulation (rTMS)
13%
Major Depressive Disorder
11%
Ligand Binding
10%
Plasmacytoma
10%
Psychiatric Illness
10%
Active Sites
10%
Affinity Maturation
8%
Association Constant
8%
High Affinity
8%
Mianserin
8%
Serotonin Receptors
8%
Univalent
8%
Human Platelets
8%
Membrane Immunoglobulin
8%
Transcranial Magnetic Stimulation
8%
Cheyne-Stokes Respiration
8%
Uptake Inhibitor
8%
Dissociation Constant
8%
Antigen Binding
8%
Epstein-Barr Virus Infections
8%
Human Lymphocytes
8%
Antibody Affinity Maturation
8%
Ligand Specificity
8%
Psychosis
8%
Detergent Solubilized
8%
Cerebrovascular Accident
8%
Rhodamine B (Rh B)
8%
Binding Characteristics
8%
Platelets
8%
Age of Onset
8%
Stimulus Duration
8%
Seizure Threshold
8%
Treatment Duration
8%
Treatment-resistant
8%
Suicide
8%
Free Treatment
8%
Nifedipine
8%
Novel Antidepressants
8%
Ketamine Anesthesia
8%
Lymphocyte Receptor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
12%
Polyacrylamide Gel Electrophoresis
10%
Plasmacytoma
10%
Iodine-125
9%
Delirium
8%
Mianserin
8%
Serotonin Receptor
8%
Rhodamine B
8%
Inositol 1 Phosphatase
8%
2,4-Dinitrophenol
8%
Troponin
8%
Inositol
8%
Clinical Pharmacokinetics
8%
Tricyclic Antidepressant
8%
Nifedipine
8%
Labetalol
8%
Tricyclic Antidepressant Overdose
8%
Immunoglobulin M
8%
Cohort Study
8%
Cerebrovascular Accident
8%
Troponin I
8%
Normal Human
8%
Antigen
8%
Lymphocyte Receptor
8%
Ketamine
8%
Cheyne Stokes Breathing
8%
Atropine
8%
Receptor
8%
Hapten
7%
Immunoglobulin A
6%
Sepharose
6%
Enzymes
5%
Fluorescein
5%
Rhodamine
5%
Urea
5%
Serotonin
5%
